Clinical Proteomics

Aims & Scope

Clinical Proteomics encompasses all aspects of translational proteomics.

Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine.

The journal is committed to rapid scientific review and timely publication of submitted manuscripts.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.3
2024	2.80

Journal Rank

Year	Value
2024	5150

Journal Citation Indicator

Year	Value
2024	427

SJR (SCImago Journal Rank)

Year	Value
2024	0.962

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	45

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

  Citation: 351

  Authors: Anna K, Joshua, Maria M, Daniel W

• Recent advances in mass spectrometry based clinical proteomics: applications to cancer research

  Citation: 253

  Authors: Andrew, Shahbaz, Thomas

• O-GlcNAc profiling: from proteins to proteomes

  Citation: 231

  Authors: Junfeng, Gerald W

• Advances in mass spectrometry-based clinical biomarker discovery

  Citation: 229

  Authors: Christopher A., Stefani N., Lori J., Daniel W.

• A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

  Citation: 203

  Authors: Bryan T., Yiling, Ana Maria, Mark S., Simen, Zhenlin, Michael A., Wenbin, Kevin, Funda, Isabelle, Mollianne, Roshan, Fan, Jens, Jan, Richard M., Wen-Lin, Joe W., Anne-Lise, Gordon B.

• Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis

  Citation: 187

  Authors: Sameh, Shymaa, Yutaka, Bo, Ying, Zam, Ilambarthi, Eishin, Tadashi

• Aberrant glycosylation associated with enzymes as cancer biomarkers

  Citation: 186

  Authors: Danni L, Daniel W

• The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

  Citation: 161

  Authors: Michael J, Maeve, Norma, Sumainizah, John, Aisling, Patricia M

• Proteomic analysis of human vitreous humor

  Citation: 125

  Authors: Krishna R, Renu, Yashwanth, Harrys KC, Praveen R, Srikanth Srinivas, Arun H, Rakesh, Nandini A, Arun, Bipin G, Venkatarangaiah, TS Keshava, Harsha, Akhilesh

• Mass spectrometry-based proteomics as an emerging tool in clinical laboratories

  Citation: 121

  Authors: Alemayehu Godana

---